In collaboration with Scientific Association of Iranian Medicinal Plants

Document Type : Research Paper

Authors

1 Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2 Islamic Azad University of Flavarjan, Iran

3 Member of young researchers Club, Islamic Azad University of Flavarjan, Iran

4 Isfahan University of Medical Sciences

Abstract

Disturbance in haemostatic system causes abnormal clots in vessels and thromboambolia. Streptokinas and urokinas are used for emergency treatment of thromboambolia. These drugs have certain limitations which cause serious and sometimes fatal consequences. Herbal preparations are considered to be safe and without side-effects. Since in ancient times it was reported that Zataria moltiflora Boiss., Curcuma domestica Valet., Cinnamomum verum J.Presl and Heracleum persicum Desf. Ex Fischer present anticoagulant effects. This study performed to evaluate fibrinolytic effects of these plants. To evaluate fibrinolytic effects, labeled fibrinogen with FITC and Ca2+ was added to human plasma. Polyphenolic extracts (0.05, 0.5, 5, 50mg/ml) without and with streptokinas, were added to labeled clot. Fluorescence was determined after 10, 20, 40 and 60 minutes (Ex=478, Em= 510). Our findings show that extract of Zataria moltiflora, Curcuma domestica and Cinnamomum verum reveal fibrinolytic effects (P<0.05). This effects are significant and dose dependable, but Heracleum persicum had no significant fibrinolytic effect (P>0.05). Fibrinolytic effects of streptokinase in presence Zataria moltiflora are increased significantly and dose dependably. This effect in presence of Curcuma domestica and Cinnamon only in 5 and 50 mg/dl are increased. Heracleum persicum does not affect fibrinolytic properties of streptokinase. The present study indicate that, Zataria moltiflora presents best fibrinolytic effect, then Curcuma domestica and Cinnamon verum respectively reveal significant fibrinolytic effect and could lysis blood clots in vitro. Consequently, we suggest that further studies to determine in vivo clot dissolving properties and active component(s) of these herbs for clot lysis are warranted.

Keywords

- صمصام شریعت، ه.، معطر، ف. و افشاری‌پور، س.، 1371. درمان با گیاه، مبانی نسخه‌پیچی گیاهی. مؤسسه انتشاراتی مشعل، اصفهان، 236 صفحه.
- میرحیدر، ح.، 1372. معارف گیاهی. جلد 2، انتشارات فرهنگ اسلامی، تهران، 749 صفحه.
- زرگری، ع.،1370. گیاهان دارویی. جلد 5، انتشارات دانشگاه تهران، 845 صفحه.
- Ammon, H.P., Safayhi, H., Mack, T. and Sabieraj, J., 1993. Mechanism of antiinflammatory action of curcumine and bowellic acids. Journal of Ethnopharmacology, 38: 105-112.
- Baruah, D.B., Dash, R.N., Chaudhari, M.R. and Kadam, S., 2006. Plasminogen activators: A comparison. Vascular Pharmacology, 44: 1-9.
- Cang, H., 1997. Pharmacology and application of chines material medicine. World Scientific, 36: 939-943.
- Capstick, T. and Henry, M.T., 2005. Efficacy of thrombolytic agents in the treatment of PE. European Respiratory Journal, 26: 864-874.
- Dahlback, B., 2000. Blood coagulation. Lancet, 355: 1627-1632.
- Fritz, R. and Fintelman, V., 2000. Herbal medicine revised and expanded. 2th ed. New York: Thieme, 1263p.
- Levine, M., 2001. Hemorrhagic complication of anticoagulant treatment. Chest, 119: 108-121.
- Makino, T.H., wakuhima, T., Okamaoto, Y., Okukubo, K., Salyo J. and Ykano, B., 2002. Effects of Kangen-karyu on coagulation system and platelet aggregation in mice. Biological Pharmaceutical Bulletin, 25(4): 523-525.
- Mills, S. and Bone, K., 2000. Principle and practice of phytotherapy. 1st ed. London: Churchil Livingston, 199p.
- Newall, C.A., Anderson, L. and Philipson, J.D., 1996. Herbal medicine guide for health care professional. The Pharmaceutical press, London, 925p.
- Pachham, M.A., 1994. Role of platelets in thrombosis and homeostasis. Journal of Physiology and Pharmacology, 72: 278-284.
- Prasad, S., Singh, K.R., Deopujari, J., Purohit, H., Taori, G. and Daginawala, H., 2007. Effect of Fagonia arabica (Dhamasa) on in vitro thrombolysis. BMC Complementary and Alternative Medicine, 7: 36-41.
- Rampart, M. and Bult, H., 1998. Complete dependent stimulation of prostacyclin biosynthesis: inhibitory by rosmarinic acid. Biochemical Pharmacology, 35: 1397-1400.
- Rasheed, A., 1981. Eugenol and phenolic essence: effect on prostaglandin and prostacyclin. England Journal of Medicine, 510: 50-56.
- Remington, 2002. The science and practice of pharmacy. 20th ed. Lippincott Wiliams and Wikins, London, 2393p.
- Sakharov, V. and Rijken, C., 2000. The effect of flow lysis of plasma clots in a plasma environment. Journal of Thrombosis and Haemostasis, 83: 469-474.
- Simmons, M.L., 1993. Individual streptokinase assessment for intracranial hemorrhage during thrombolytic therapy. Lancet, 342: 1523-1528.
- Stiene-Martin, E.A., Lotspeich, C.A. and Koepke, J.A., 1997. Clinical hematology, principles, procedures, correlation. 2th ed., Lippist Philladellphia, NewYork, 848p.
- Sweta, P., Rajpal, S., Jayant, D., Hemant, P., Girdhar, T. and Hatim, D., 2007. Effect of Fagonia arabica (Dhamasa) on in vitro thrombolysis. BMC Complementary and Alternative Medicine, 7: 36-41.
- Wardlaw, J.M., Berge, E., del Zoppo, G. and Yamaguchi, T., 2004. Thrombolysis for acute ischemic stroke. Stroke, 35: 2914-2915.
- Zimbelman, J., 2000. Unusual complication of warfarin therapy: skin necrosis and priapism. Journal of Pediatric, 137: 266-268.